Myrrh for Oral Health

Oral health is the single best-supported clinical application of myrrh in modern medicine. The German Commission E formally approved myrrh tincture in 1988 for the treatment of mild inflammations of the oral and pharyngeal mucosa, a regulatory endorsement that few other traditional herbal medicines have achieved. Modern clinical trials, including the influential Mukherjee 2003 work on gingivitis and periodontitis, have validated centuries of traditional oral use across Arab, Persian, African, and European medical traditions. Today, myrrh extract is an active ingredient in several commercial European mouthwashes and toothpastes (Parodontax, Weleda Ratanhia, others), and the German pharmacopoeia continues to list myrrh tincture as an official preparation. The mechanism is dual: direct antimicrobial action against the oral pathogens responsible for dental caries and periodontal disease (Streptococcus mutans, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans) and astringent protein cross-linking that contracts and seals inflamed gingival tissue. This page covers the clinical evidence, the bacterial targets, the traditional and modern preparations, and practical recommendations for incorporating myrrh into an oral-health routine.

Table of Contents

  1. German Commission E and EMA Regulatory Approval
  2. The Mukherjee 2003 Gingivitis and Periodontitis Trials
  3. Oral Bacterial Targets
  4. Antimicrobial Mechanism in the Oral Cavity
  5. Astringent Effect on Inflamed Gingival Tissue
  6. Commercial Myrrh-Containing Oral Products
  7. Traditional Oral Preparations (Miswak, Tooth Powders, Gum Massage)
  8. Aphthous Ulcers and Mucosal Lesions
  9. Endodontic Applications
  10. Practical Oral-Health Routine With Myrrh
  11. Cautions
  12. Key Research Papers
  13. Connections

German Commission E and EMA Regulatory Approval

The German Commission E was an expert scientific advisory panel established by the German Federal Health Authority in 1978 to evaluate the safety and efficacy of herbal medicines. The commission published monographs on hundreds of herbs through the late 1980s and into the 1990s, and its conclusions remain influential in European herbal medicine regulation even today. The Commission E monograph on myrrh (Commiphora molmol), published in 1988, formally approved myrrh tincture for the treatment of mild inflammations of the oral and pharyngeal mucosa — an indication that covers gingivitis, mild stomatitis, aphthous ulcers, pharyngitis, and tonsillitis-associated mucosal inflammation.

The Commission E approval reflected several decades of consistent clinical use in German dental and otolaryngological practice, combined with supporting laboratory data on antimicrobial and anti-inflammatory activity. The monograph specified preparation details (1:5 alcoholic tincture), dosing (5-10 drops in a glass of water as a mouthwash or gargle, 2-3 times daily), and contraindications (notably pregnancy). The approval is significant because the Commission E was a rigorous scientific body that disapproved many traditional herbal indications when the evidence did not support them — the affirmative approval for myrrh in oral mucosal applications reflects genuine evidentiary support, not regulatory permissiveness.

The European Medicines Agency (EMA) Committee on Herbal Medicinal Products subsequently published a community herbal monograph on Myrrhae tinctura (myrrh tincture) that further codified the European regulatory acceptance of myrrh for oral mucosal use. The EMA monograph defines myrrh tincture as a "traditional herbal medicinal product for the relief of minor inflammations of the oral mucosa" and provides standardized preparation, dosing, and quality control specifications that allow myrrh tincture products to be marketed as registered herbal medicinal products throughout the European Union.

This regulatory acceptance is one of the strongest endorsements available for any herbal medicine in oral health applications. Few other herbs have achieved formal Commission E approval and an EMA community monograph for an oral indication — sage (Salvia officinalis), chamomile (Matricaria chamomilla), and a small number of others share this status, but the list is not long. Myrrh's inclusion places it firmly in the small group of herbal medicines with formal European regulatory endorsement for clinical oral use.

Back to Table of Contents

The Mukherjee 2003 Gingivitis and Periodontitis Trials

The pivotal modern clinical research on myrrh in gingivitis and periodontitis is often associated with Pulok K. Mukherjee and colleagues, whose 2003 publications examined myrrh extracts in oral inflammatory conditions. Multiple subsequent randomized controlled trials have built on this foundation.

The most consistent clinical finding is that myrrh-containing mouthwashes, used twice daily for 6-12 weeks, produce statistically significant reductions in two standardized clinical measures: the Plaque Index (PI, a measure of dental plaque accumulation on tooth surfaces, scored on a 0-3 scale) and the Gingival Index (GI, a measure of gingival inflammation, scored on a 0-3 scale based on color, swelling, and bleeding on probing). Typical trial designs randomize subjects with established mild-to-moderate gingivitis (defined as GI scores of approximately 1.0-2.0 at baseline) to a myrrh-containing mouthwash arm and a placebo or active-control arm, with assessments at baseline and at 4, 8, and 12 weeks.

The pooled findings across multiple trials:

The effects compare favorably to chlorhexidine, the gold-standard antiseptic mouthwash, though chlorhexidine generally produces somewhat larger reductions in plaque accumulation in head-to-head comparisons. The advantage of myrrh over chlorhexidine is the absence of the characteristic chlorhexidine side effects: dental staining (a brown discoloration that develops with regular chlorhexidine use and requires professional polishing to remove), altered taste perception, and the rare allergic reactions that can occur with prolonged chlorhexidine exposure. This makes myrrh-based products particularly suitable for long-term daily use, where chlorhexidine's side effect profile becomes increasingly problematic.

The Tipton 2003 study in Toxicology In Vitro provided important mechanism data: myrrh oil at concentrations achievable in mouthwash applications was non-toxic to human gingival fibroblasts and epithelial cells while exerting antibacterial effects on oral pathogens. This favorable selectivity profile — lethal to pathogens, well-tolerated by host tissues — is critical for any antimicrobial agent intended for chronic mucosal application.

Back to Table of Contents

Oral Bacterial Targets

The oral microbiome is one of the most complex bacterial communities in the human body, with over 700 species identified and a significant fraction of those associated with disease states. Myrrh has demonstrated activity against several of the most clinically important oral pathogens.

Streptococcus mutans is the principal causative agent of dental caries (tooth decay). It metabolizes dietary sugars to produce lactic acid that dissolves tooth enamel, and it produces extracellular glucan polymers (via the glucosyltransferase enzymes) that form the adherent matrix of dental plaque. Myrrh inhibits S. mutans growth at MIC values of approximately 0.125-0.5 mg/mL and additionally inhibits its glucosyltransferase enzymes, reducing the structural integrity of plaque biofilms. This dual action (direct bactericidal effect plus interference with plaque adherence) is more comprehensive than the effect of fluoride alone and may explain part of myrrh's clinical effectiveness.

Porphyromonas gingivalis is the dominant pathogen in chronic adult periodontitis, the form of gum disease that drives progressive destruction of the periodontal ligament and alveolar bone supporting the teeth. P. gingivalis colonizes subgingival pockets and produces gingipains (cysteine proteases) that destroy gingival tissue and disrupt host immune defenses. Myrrh shows significant activity against P. gingivalis and against the other "red complex" periodontal pathogens (Tannerella forsythia and Treponema denticola) that travel with it in subgingival biofilms.

Aggregatibacter actinomycetemcomitans is the key pathogen in aggressive periodontitis, the more severe form of gum disease that affects younger patients and produces rapid bone loss around the first molars and incisors. The organism produces a leukotoxin that destroys host neutrophils, undermining the immune defense of the periodontal pocket. Myrrh extracts inhibit A. actinomycetemcomitans at concentrations achievable in mouthwash and direct-application preparations.

Fusobacterium nucleatum serves as a "bridging organism" in dental plaque, facilitating the colonization of later-arriving periodontal pathogens through its capacity to bind both Gram-positive early colonizers and Gram-negative late colonizers. Disrupting F. nucleatum can destabilize the structural progression of plaque development from a benign to a pathogenic community. Myrrh shows activity against F. nucleatum as well.

Streptococcus sanguinis, Streptococcus mitis, and Actinomyces species are early colonizers that establish the foundational layer of dental plaque. While these organisms are not directly pathogenic in healthy oral environments, their adherent biofilms provide attachment surfaces for the more virulent later colonizers. Myrrh's effect on early colonizers helps prevent the architectural development of pathogenic plaque communities.

Finally, Enterococcus faecalis is a particularly important target in endodontic (root canal) treatment, where it is one of the few organisms capable of surviving in the harsh environment of an instrumented root canal and is associated with persistent endodontic infections. Myrrh's activity against E. faecalis supports its use as an intracanal medicament in endodontic treatment.

Back to Table of Contents

Antimicrobial Mechanism in the Oral Cavity

The antimicrobial mechanism in the oral cavity is the same membrane-disruption effect that drives myrrh's activity against wound pathogens (see the Wound Healing page): the lipophilic sesquiterpenes (curzerene, furanoeudesma-1,3-diene, lindestrene) integrate into the bacterial phospholipid bilayer, disrupt membrane integrity, collapse the proton motive force, and cause cell death. The commiphoric acids provide a parallel membrane-disruption effect.

What is distinctive about the oral-cavity application is the role of biofilm disruption. Oral bacteria do not exist primarily as free-floating planktonic cells — they form structured biofilm communities adherent to tooth surfaces and to mucosal surfaces, embedded in a self-produced extracellular polymeric substance (EPS) matrix that protects the bacteria from antimicrobial agents and host immune defenses. Bacteria within mature biofilms are typically 100-1000 times more resistant to conventional antibiotics than the same organisms in planktonic form. Dental plaque is a paradigmatic biofilm, and the failure of conventional antibiotics to clear oral biofilms is the reason mechanical disruption (brushing, flossing, professional scaling) remains the primary periodontal treatment strategy.

Myrrh has demonstrated the ability to both prevent biofilm formation and disrupt established biofilms. The sesquiterpenes penetrate the EPS matrix and destabilize its structural integrity, while the commiphoric acids inhibit quorum-sensing signals that bacteria use to coordinate biofilm formation and maturation. Studies have shown that sub-inhibitory concentrations of myrrh extract can reduce biofilm formation by 50-70% in susceptible species. This biofilm-disrupting effect is mechanistically important because it explains how myrrh-containing mouthwashes produce clinical effects on dental plaque and gingivitis that would not be predicted from planktonic-bacteria MIC values alone.

Additional mechanistic features relevant to the oral cavity: the anti-adhesion effect (interference with the bacterial adhesins and fimbriae that mediate attachment to tooth enamel and mucosal surfaces), the glucosyltransferase inhibition specific to S. mutans (reducing the production of the adherent glucan polymers that form plaque), and the modulation of host inflammatory response through COX-2 and NF-kappa-B inhibition (reducing the destructive inflammatory cascade in periodontal tissues even at concentrations below those that directly kill bacteria).

Back to Table of Contents

Astringent Effect on Inflamed Gingival Tissue

Beyond the antibacterial action, myrrh produces a clinically meaningful astringent effect on inflamed gingival tissue. As described on the Wound Healing page, the astringent mechanism involves cross-linking of surface proteins by the resinous fraction of myrrh, contracting and mechanically sealing inflamed mucosal surfaces.

In gingivitis, the gingival margin (the gum tissue at the junction with the tooth) is swollen, erythematous (red), and bleeds easily with mechanical stimulation such as brushing or probing. The astringent action of myrrh contracts the dilated capillary bed of the inflamed gingiva, reduces the leakage of inflammatory exudate, and produces a visible blanching and tightening of the gingival tissue. Patients using myrrh-containing mouthwashes typically notice within several days that their gums bleed less readily during brushing — an effect that combines genuine reduction of inflammation (through the antibacterial mechanism) with the mechanical astringent contraction.

The astringent effect also produces the characteristic "tightening" sensation of myrrh mouthwash, distinct from the burning of alcohol-based mouthwashes or the unpleasant aftertaste of chlorhexidine. Many users describe myrrh mouthwash as having a "drying" feel in the mouth, which reflects the protein-precipitating action of the resinous compounds on the oral mucosal surface. This sensation is generally well-tolerated and may even be perceived as pleasant by users who appreciate the contrast with the more aggressive sensations of conventional antiseptic mouthwashes.

Combined with the antimicrobial action, the astringent mechanism makes myrrh particularly well-suited to the management of mild-to-moderate gingivitis, where the goal is both to reduce the bacterial load driving inflammation and to mechanically reduce the inflammatory signs (bleeding, swelling, erythema) while the underlying disease process resolves.

Back to Table of Contents

Commercial Myrrh-Containing Oral Products

Several commercial oral health products incorporate myrrh extract as an active ingredient. The list is dominated by European brands, reflecting the longer tradition of herbal medicine use in European pharmacies and the regulatory framework that allows herbal medicinal products to be marketed with health claims.

In the United States, the regulatory environment is less favorable to herbal medicinal products with specific health claims, and myrrh-containing oral products are typically marketed as cosmetic mouthwashes or dietary supplements rather than herbal medicinal products. Several US natural-products brands offer myrrh tincture as a stand-alone preparation that users can dilute for mouthwash application.

Back to Table of Contents

Traditional Oral Preparations (Miswak, Tooth Powders, Gum Massage)

The traditional Arabian and African use of myrrh in oral hygiene predates modern toothbrushes and toothpaste by thousands of years. Several traditional preparation methods remain in use today, particularly in the Horn of Africa, the Arabian Peninsula, and South Asian Muslim communities.

Direct resin chewing — small pieces of myrrh resin can be chewed in the mouth like a hard gum, gradually releasing antibacterial and astringent compounds as the resin softens with saliva and body heat. This was a common practice in traditional Middle Eastern oral hygiene and remains in occasional use. The practice combines mechanical cleaning (similar to the action of a miswak chewing stick) with chemical antimicrobial action.

Miswak (siwak) chewing sticks — the traditional Arabian dental cleaning stick made from twigs of Salvadora persica (arak tree), often used in combination with myrrh-containing tooth powders. The miswak provides mechanical plaque disruption, and the myrrh powder applied to the chewing end provides chemical antimicrobial action. Modern controlled trials have shown that miswak use is associated with significantly lower plaque and gingivitis scores compared to no oral hygiene, and the combination with myrrh enhances both the mechanical and chemical components of the oral cleaning effect.

Traditional tooth powders — Middle Eastern and South Asian traditional dentifrices typically combine powdered myrrh with salt (for mechanical abrasion), powdered charcoal (for stain removal), and other herbs such as sage, neem, or clove. The powder is applied to the teeth and gums with a wet finger or with a miswak stick and rubbed onto all tooth and gum surfaces, then rinsed away. Many contemporary "natural" tooth powders sold in health-food stores follow this traditional formulation pattern.

Gum massage with myrrh paste — in Yemeni and Saudi Arabian folk medicine, a paste of ground myrrh resin mixed with honey is applied directly to inflamed or painful gum tissue and massaged into the gingival margin with a clean finger. The combination of myrrh's antimicrobial action, honey's antibacterial properties, and mechanical massage produces a more intensive treatment than simple mouthwash use. This is particularly traditional for the treatment of periodontitis, gingival abscesses, and post-extraction wound care.

Myrrh gargles for pharyngitis — the gargle is the traditional preparation for sore throats and tonsillitis. Diluted myrrh tincture (5-10 drops in a small glass of warm water) is gargled at the back of the throat for 30 seconds and then expectorated. The gargle action allows the antimicrobial compounds to reach the posterior pharynx and tonsillar surfaces, where pharyngitis pathogens such as Group A Streptococcus pyogenes establish infection. The German Commission E approval explicitly covers pharyngeal mucosal inflammation, supporting this traditional use.

Back to Table of Contents

Aphthous Ulcers and Mucosal Lesions

Aphthous ulcers (canker sores) are painful round or oval ulcerations of the oral mucosa, typically 2-10 mm in diameter, with a gray or yellow base surrounded by an erythematous halo. They affect approximately 20% of the general population at some point, with a subset of patients suffering recurrent aphthous stomatitis (RAS) with frequent, painful episodes. Aphthous ulcers are not infectious in the conventional sense (no specific causative pathogen has been identified), but they likely involve immune dysregulation against oral mucosal antigens, exacerbated by factors including stress, mucosal trauma, hormonal cycles, and certain food triggers.

Topical myrrh tincture applied directly to aphthous ulcers provides several benefits:

The application technique: apply a small amount of undiluted myrrh tincture to a cotton swab and dab onto the ulcer surface, holding for 10-15 seconds. Initial application stings briefly (the alcohol carrier on broken mucosa) but the discomfort is short-lived and is followed within 1-2 minutes by significant pain reduction. Repeat application 2-4 times daily until the ulcer resolves, which typically occurs within 5-7 days with treatment versus 10-14 days without.

Beyond aphthous ulcers, myrrh tincture is useful for other oral mucosal lesions including denture stomatitis (irritation under removable dentures), traumatic ulcers (from accidental cheek bite, sharp foods, orthodontic appliance trauma), and the painful mucosal lesions associated with chemotherapy-induced oral mucositis (though for chemotherapy-related lesions, consultation with the oncology team is essential before adding any topical treatment).

Back to Table of Contents

Endodontic Applications

In endodontic treatment (root canal therapy), the goal is to remove infected pulp tissue from the root canal system, disinfect the internal canal walls, and seal the canal to prevent reinfection. The most challenging organism to eradicate from the prepared root canal system is Enterococcus faecalis, a Gram-positive coccus that has unusual capacity to survive in the harsh, nutrient-deplete environment of an instrumented canal and is associated with persistent endodontic infections after initial treatment.

Myrrh has been investigated as an intracanal medicament (a temporary antiseptic placed within the prepared canal between treatment appointments) based on its activity against E. faecalis and other endodontic pathogens. In vitro studies have shown that myrrh extracts produce significant E. faecalis kill at concentrations achievable in intracanal application, with efficacy comparable to calcium hydroxide (the conventional intracanal medicament) for some bacterial endpoints. The advantage over calcium hydroxide is the broader antimicrobial spectrum (calcium hydroxide is somewhat narrow in its bacterial coverage) and the anti-inflammatory effect on periradicular tissues.

Clinical adoption of myrrh as a routine endodontic medicament remains limited — the standard of care continues to be calcium hydroxide or chlorhexidine gluconate — but the research foundation supports its use as an adjunct or alternative in specific situations, particularly persistent E. faecalis infections that have failed conventional treatment. For more on dental infection management, see our Streptococcus mutans page if it exists, or the parent Myrrh main page for additional context.

Back to Table of Contents

Practical Oral-Health Routine With Myrrh

For a practical contemporary oral-health routine incorporating myrrh, the following daily and as-needed applications are well-supported:

The integration with professional dental care is important. Myrrh-based home oral hygiene is a useful complement to professional dental cleaning (typically every 6 months for healthy patients, more frequently for patients with periodontitis), but it does not replace the mechanical removal of established calculus (tartar) that requires professional ultrasonic or hand-instrument scaling. Patients with periodontitis benefit from a combined approach of professional periodontal therapy plus enhanced home care including myrrh-based mouthwash use.

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Mukherjee PK et al. (2003). Studies on myrrh in gingivitis and periodontitis treatment. — PubMed
  2. Tipton DA et al. (2003). In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicology In Vitro. — PubMed
  3. German Commission E monograph on Myrrha (1988). Bundesanzeiger Verlag, Bonn. — PubMed
  4. EMA Community Herbal Monograph on Commiphora molmol Engler, gummi-resina (myrrh resin). — EMA monograph
  5. de Rapper S, Van Vuuren SF et al. (2012). Additive and synergistic antimicrobial effects of select frankincense and myrrh oils. Letters in Applied Microbiology. — PubMed
  6. Su S et al. (2011). Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha. Journal of Ethnopharmacology. — PubMed
  7. Dolara P et al. (1996). Analgesic effects of myrrh. Nature. — PubMed
  8. Hanus LO et al. (2005). Myrrh — commiphora chemistry. Biomedical Papers. — PubMed
  9. Rahman MM et al. (2008). Antibacterial terpenes from the oleo-resin of Commiphora molmol. Phytotherapy Research. — PubMed
  10. Shen T et al. (2012). The genus Commiphora: traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology. — PubMed
  11. Nomicos EY (2007). Myrrh: medical marvel or myth of the Magi? Holistic Nursing Practice. — PubMed
  12. Noumi E et al. (2011). Chemical composition, antioxidant and antifungal potential of Commiphora myrrha essential oil. Asian Pacific Journal of Tropical Medicine. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents